Inhibitory effect of local administration of Lactobacillus rhamnosus K03 (L8020) on peri-implantitis with suppuration

Yasuda Keisuke0 个研究点目标入组 10 人开始时间: 2023年9月13日最近更新: 2024年5月27日

适应症

试验速览

暂无简介。

•1. Persons who are 18 years of age or older at the time consent is obtain
•2. Those who can obtain written consent from the individual to participate in this study
•3. Patients with implants that meet the diagnostic criteria for peri-implantitis for at least one year at the time of study entry.
•Peri-implantitis is defined as patients who meet the following diagnostic criteria
•i) Inflammation around the implant
•ii) Bone resorption around the implant
•4. Patients with implants that have been known to drain for at least 3 months and have drained within 1 week prior to enrollment.

•1. Patients who have received a lactic acid bacteria preparation, bifidobacteria preparation, butyric acid bacteria preparation, or this drug as a prescription drug within 3 months prior to the start of administration of this drug.
•2. Patients who have experienced serious adverse reactions to lactic acid bacteria, bifidobacteria, butyric acid bacteria, or this drug as ethical drugs in the past.
•3. Patients who have received antimicrobial agents administered topically in the oral cavity or systemically by oral administration, etc. within 7 days.
•4. Patients already using this drug.

发起方

Yasuda Keisuke